Related Experiment Video
Updated: Aug 2, 2026

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
Recent developments in Kawasaki disease
1Department of Pediatrics, The Children's Memorial Hospital, Northwestern University Medical School, Chicago, Illinois 60614-3363, USA. freeman_alexandra@hotmail.com
Insights
Kawasaki disease is a leading cause of acquired heart disease in children. Research is exploring its infectious causes, inflammatory responses, and treatments for resistant cases.
Area of Science:
- Pediatrics
- Cardiology
- Immunology
Background:
- Kawasaki disease is the primary cause of acquired heart disease in children in North America and Japan.
- Understanding the etiology and pathogenesis of Kawasaki disease is crucial for effective management.
Purpose of the Study:
- To review recent developments and controversies surrounding Kawasaki disease.
- To highlight advances in understanding its infectious causes, inflammatory mechanisms, and therapeutic strategies.
Main Methods:
- Literature review of recent studies on Kawasaki disease.
- Analysis of immunohistochemistry findings related to coronary artery lesions.
- Examination of research on treatment resistance and long-term outcomes.
Main Results:
- Growing evidence supports an infectious origin, with ongoing debate on antigen involvement (conventional vs. superantigen).
- Vascular growth factors are implicated in coronary artery lesion formation.
- Focus on identifying and treating therapy-resistant patients and understanding long-term prognosis.
Conclusions:
- Recent advances provide insights into the etiology, pathogenesis, and therapy of Kawasaki disease.
- Further research is needed to fully elucidate the complex mechanisms driving this condition.
- Improved understanding will aid in developing more targeted and effective treatments for affected children.
Abstract:
Kawasaki disease is now being recognized as the leading cause of acquired heart disease in children in North America and Japan. This review discusses the recent developments and controversies in Kawasaki disease. Increasing evidence has supported an infectious etiology for Kawasaki disease; however, the debate continues as to whether the inflammatory response results from a conventional antigen or a superantigen. Recent immunohistochemistry findings suggest many vascular growth factors then play a role in the formation of the coronary artery lesions. Many studies have focused on the identification and therapy for patients resistant to conventional therapy, as well as the long-term prognosis of Kawasaki disease survivors. The recent advances in Kawasaki disease are helping to provide some clues in the etiology, pathogenesis and therapy for Kawasaki disease.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis III: Medical Management
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
